{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:29:06Z","timestamp":1788571746692,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"PLA foundation, China","award":["BWS16J010;"],"award-info":[{"award-number":["BWS16J010;"]}]},{"name":"PLA foundation, China","award":["AWS14L008"],"award-info":[{"award-number":["AWS14L008"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cbi.2019.04.024","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T10:42:58Z","timestamp":1555670578000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT\/ GSK-3\u03b2 signaling pathway"],"prefix":"10.1016","volume":"307","author":[{"given":"Linlin","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lv","family":"Pin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Shun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.04.024_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"10.1016\/j.cbi.2019.04.024_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"22","key":"10.1016\/j.cbi.2019.04.024_bib3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.cbi.2019.04.024_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1471-4914(03)00114-X","article-title":"The molecular basis of myocardial hypertrophy and heart failure","volume":"9","author":"Ritter","year":"2003","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.cbi.2019.04.024_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phrs.2009.11.012","article-title":"Molecular targets and regulators of cardiac hypertrophy","volume":"61","author":"Rohini","year":"2010","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.cbi.2019.04.024_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI62839","article-title":"Signaling effectors underlying pathologic growth and remodeling of the heart","volume":"123","author":"van Berlo","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.cbi.2019.04.024_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/CIRCRESAHA.109.209338","article-title":"Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors","volume":"106","author":"Bush","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2019.04.024_bib8","first-page":"928326","article-title":"Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy","volume":"2011","author":"Kee","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.cbi.2019.04.024_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.cbi.2019.04.024_bib10","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","article-title":"Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy","volume":"113","author":"Kong","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cbi.2019.04.024_bib11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI19137","article-title":"Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop","volume":"112","author":"Kook","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.cbi.2019.04.024_bib12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1139\/cjpp-2016-0542","article-title":"Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy","volume":"95","author":"Raghunathan","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2019.04.024_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm1552","article-title":"Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity","volume":"13","author":"Trivedi","year":"2007","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.cbi.2019.04.024_bib14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/ptr.2217","article-title":"A 90 day repeated oral toxicity study on plantamajoside concentrate from Plantago asiatica","volume":"21","author":"Park","year":"2007","journal-title":"Phytother Res."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2019.04.024_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.01.028","article-title":"Psyllium as therapeutic and drug delivery agent","volume":"334","author":"Singh","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"16","key":"10.1016\/j.cbi.2019.04.024_bib16","first-page":"2095","article-title":"[Qualitative and quantitative analysis of plantamajoside in Plantaginis Herba]","volume":"35","author":"Sun","year":"2010","journal-title":"Zhongguo Zhongyao Zazhi"},{"issue":"5","key":"10.1016\/j.cbi.2019.04.024_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3883","article-title":"UHPLC-MS\/MS determination and pharmacokinetic study of plantamajoside in rat plasma after oral administration of single plantamajoside and Plantago asiatica extract","volume":"31","author":"Bai","year":"2017","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.cbi.2019.04.024_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jpba.2013.11.014","article-title":"Pharmacokinetics of plantamajoside and acteoside from Plantago asiatica in rats by liquid chromatography-mass spectrometry","volume":"89","author":"Li","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.cbi.2019.04.024_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.etap.2014.11.012","article-title":"Nephroprotection of plantamajoside in rats treated with cadmium","volume":"39","author":"Jung","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.cbi.2019.04.024_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.intimp.2016.04.013","article-title":"Plantamajoside ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-kappaB and MAPK activation","volume":"35","author":"Wu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cbi.2019.04.024_bib21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1186\/s12885-015-1960-z","article-title":"Plantamajoside, a potential anti-tumor herbal medicine inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of matrix metalloproteinase-9 and -2","volume":"15","author":"Pei","year":"2015","journal-title":"BMC Canc."},{"issue":"3","key":"10.1016\/j.cbi.2019.04.024_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ptr.2316","article-title":"Glycation inhibitory activity and the identification of an active compound in Plantago asiatica extract","volume":"22","author":"Choi","year":"2008","journal-title":"Phytother Res."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2019.04.024_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-012-1424-6","article-title":"Tetrodotoxin attenuates isoproterenol-induced hypertrophy in H9c2 rat cardiac myocytes","volume":"371","author":"Chen","year":"2012","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.cbi.2019.04.024_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11427-011-4183-9","article-title":"Distinct actions of intermittent and sustained beta-adrenoceptor stimulation on cardiac remodeling","volume":"54","author":"Ma","year":"2011","journal-title":"Sci. China Life Sci."},{"issue":"5","key":"10.1016\/j.cbi.2019.04.024_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-2006-958143","article-title":"Phenylethanoids in the herb of Plantago lanceolata and inhibitory effect on arachidonic acid-induced mouse ear edema","volume":"61","author":"Murai","year":"1995","journal-title":"Planta Med."},{"issue":"5","key":"10.1016\/j.cbi.2019.04.024_bib26","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.3390\/molecules17055459","article-title":"Isolation and characterization of phenolic antioxidants from Plantago herb","volume":"17","author":"Amakura","year":"2012","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.cbi.2019.04.024_bib27","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/ptr.3071","article-title":"Bioguided isolation of angiotensin-converting enzyme inhibitors from the seeds of Plantago asiatica L","volume":"24","author":"Geng","year":"2010","journal-title":"Phytother Res."},{"issue":"23","key":"10.1016\/j.cbi.2019.04.024_bib28","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1111\/bph.13133","article-title":"A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2\/ROS\/p38 pathway","volume":"172","author":"Yin","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.cbi.2019.04.024_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-2828(85)80130-9","article-title":"Catecholamine cardiotoxicity","volume":"17","author":"Rona","year":"1985","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cbi.2019.04.024_bib30","doi-asserted-by":"crossref","first-page":"23693","DOI":"10.1038\/srep23693","article-title":"Paeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress: roles of Nrf2\/HO-1 and PI3K\/Akt pathway","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cbi.2019.04.024_bib31","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.bjp.0707622","article-title":"Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis","volume":"153","author":"Kiriazis","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.cbi.2019.04.024_bib32","article-title":"Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.cbi.2019.04.024_bib33","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.RES.0000338570.27156.84","article-title":"Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy","volume":"103","author":"Kee","year":"2008","journal-title":"Circ. Res."},{"issue":"25","key":"10.1016\/j.cbi.2019.04.024_bib34","doi-asserted-by":"crossref","first-page":"22011","DOI":"10.1074\/jbc.M101579200","article-title":"Identification and characterization of a sac domain-containing phosphoinositide 5-phosphatase","volume":"276","author":"Minagawa","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.cbi.2019.04.024_bib35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI24178","article-title":"Protein kinase cascades in the regulation of cardiac hypertrophy","volume":"115","author":"Dorn","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.cbi.2019.04.024_bib36","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1073\/pnas.231619298","article-title":"Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo","volume":"99","author":"Antos","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.cbi.2019.04.024_bib37","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.0000018952.70505.F1","article-title":"Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development","volume":"90","author":"Hardt","year":"2002","journal-title":"Circ. Res."},{"issue":"26","key":"10.1016\/j.cbi.2019.04.024_bib38","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.2174\/1381612824666180903123423","article-title":"Computer-aided drug design and drug pharmacokinetic prediction: a mini-review","volume":"24","author":"Tabeshpour","year":"2018","journal-title":"Curr. Pharmaceut. Des."},{"issue":"21","key":"10.1016\/j.cbi.2019.04.024_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700258","article-title":"Tailored approaches in drug development and diagnostics: from molecular design to biological model systems","volume":"6","author":"Sahlgren","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.cbi.2019.04.024_bib40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.compbiolchem.2018.06.005","article-title":"Docking techniques in pharmacology: how much promising?","volume":"76","author":"Gupta","year":"2018","journal-title":"Comput. Biol. Chem."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718317307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718317307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:52:53Z","timestamp":1757857973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718317307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":40,"alternative-id":["S0009279718317307"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.04.024","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT\/ GSK-3\u03b2 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}